Wolfson Medical Center
wolfson.org.ilTotal trials
112
Active
12
Phase 3
6
Total enrollment
11,651
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Acetaminophen | — | — | — | — | — | 2 | |
| Dipyrone | — | — | — | — | — | 2 | |
| Tranexamic acid | — | — | — | — | 2 | ||
| Oral Budesonide | — | — | — | — | — | 1 |
Next readouts
- 2026-03-01
- 2027-05-01
- 2027-12-01
Top conditions
- Anxiety5
- Ulcerative Colitis4
- ARDS3
- Asthma3
- Induction of Labor Affected Fetus / Newborn2
- Obesity2
- Pain2
- Myelodysplastic Syndrome2
Frequently asked questions about Wolfson Medical Center
- How many clinical trials does Wolfson Medical Center have on ClinicalTrials.gov?
- Wolfson Medical Center is listed as the lead sponsor on 112 clinical trials in ClinicalTrials.gov, 12 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Wolfson Medical Center's trials are in Phase 3?
- 6 of Wolfson Medical Center's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Wolfson Medical Center focus on?
- Wolfson Medical Center's most-studied conditions on ClinicalTrials.gov are Anxiety, Ulcerative Colitis, ARDS, Asthma, Induction of Labor Affected Fetus / Newborn.
- When are Wolfson Medical Center's next clinical trial readouts?
- Wolfson Medical Center has 3 upcoming primary-completion readouts tracked here; the soonest is “Combination of Diet and Oral Budesonide for Ulcerative Colitis”, expected around 2026-03-01.